Title |
Treatment of Cryptosporidium: What We Know, Gaps, and the Way Forward
|
---|---|
Published in |
Current Tropical Medicine Reports, August 2015
|
DOI | 10.1007/s40475-015-0056-9 |
Pubmed ID | |
Authors |
Hayley Sparks, Gayatri Nair, Alejandro Castellanos-Gonzalez, A. Clinton White |
Abstract |
Cryptosporidiosis is increasingly recognized as an important global health concern. While initially reported in immunocompromised such as AIDS patients, cryptosporidiosis has now been documented as a major cause of childhood diarrhea and an important factor in childhood malnutrition. Currently, nitazoxanide is the only proven anti-parasitic treatment for Cryptosporidium infections. However, it is not effective in severely immunocompromised patients and there is limited data in infants. Immune reconstitution or decreased immunosuppression is critical to therapy in AIDS and transplant patients. This limitation of treatment options presents a major public health challenge given the important burden of disease. Repurposing of drugs developed for other indications and development of inhibitors for novel targets offer hope for improved therapies, but none have advanced to clinical studies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 174 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 40 | 23% |
Student > Ph. D. Student | 18 | 10% |
Researcher | 14 | 8% |
Student > Master | 12 | 7% |
Student > Doctoral Student | 9 | 5% |
Other | 27 | 16% |
Unknown | 54 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 29 | 17% |
Medicine and Dentistry | 22 | 13% |
Agricultural and Biological Sciences | 18 | 10% |
Immunology and Microbiology | 18 | 10% |
Chemistry | 7 | 4% |
Other | 22 | 13% |
Unknown | 58 | 33% |